2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.68+$0.005 (+0.30%)
Price as of Jun 03, 2026 4:55 PM EDT- $231.1MMarket Cap
- -15.66%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.68+$0.005 (+0.30%)
IKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.67 | ||
Change | -$0.03 (-1.76%) | ||
Open | $1.70 | ||
High | $1.74 | ||
Low | $1.65 | ||
Previous Close | $1.70 | ||
Volume | 845,808 | ||
30-Day Average Volume | 693,933 | ||
1-Week Change | -1.76% | ||
1-Month Change | -12.57% | ||
1-Year Change | -15.66% | ||
3-Year Change | -60.86% | ||
5-Year Change | -94.82% | ||
Fundamentals | |||
Shares Outstanding | 132.0M | ||
Total Assets | $173.3M | ||
Market Cap | $231.1M | ||
Enterprise Value | $181.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$16.4M | ||
Free Cash Flow | -$12.1M | ||
EBIT | -$16.4M | ||
EBITDA | -$16.4M | ||
Net Working Capital | $166.5M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 124 | ||
P/B | 1 | ||
P/E | -18 | ||
PEG | -6 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/30/2023 | ||
Earnings & Revenue